Internal Medicine, Rheumatology · Queensbury, NY
NPI
1508952953
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
161 Carey Rd
Queensbury, NY, 12804
Phone (518) 824-8610
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
58,234 services
Medicare patients, 2024
510
Average age 72
Drug cost, 2024
$5.3M
1,597 prescriptions
Company payments, 2025
$82K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard M Bryan was code J1602 (injection, golimumab, 1 mg, for intravenous use), 16,223 times for 22 patients. In total Richard M Bryan billed 58,234 services in 43 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 16,223 | 22 | $8.79 | $143K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 7,647 | 20 | $24.74 | $189K |
| J0897 Injection, denosumab, 1 mg | Office | 3,000 | 34 | $20.23 | $61K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 702 | 68 | $0.75 | $530 |
| 99214 Office E&M - Established | Office | 538 | 353 | $79.13 | $43K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 525 | 352 | $12.42 | $6,521 |
| 96415 Chemotherapy Administration | Office | 340 | 31 | $21.21 | $7,211 |
| 96413 Chemotherapy Administration | Office | 300 | 62 | $97.18 | $29K |
| 99215 Office E&M - Established | Office | 192 | 115 | $136.49 | $26K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 176 | 32 | $0.52 | $91.15 |
| 36415 Venipuncture Blood Collection | Office | 173 | 102 | $6.78 | $1,173 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 100 | 20 | $4.95 | $495 |
| 20610 Joint Injection | Office | 91 | 57 | $49.22 | $4,479 |
| 96365 Intravenous Infusion, Hydration | Office | 90 | 39 | $47.37 | $4,263 |
| 99205 Office E&M - New | Office | 63 | 63 | $169.96 | $11K |
By year: 2022 $724K for 35,472 services; 2023 $894K for 48,310 services; 2024 $1.0M for 58,234 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 173 | 102 | $6.78 | $1,173 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard M Bryan prescribed most often to Medicare patients was Prednisone, with 291 prescriptions and refills. In total Richard M Bryan wrote 1,597 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 291 | 454 | 121 | $1,730 |
| Celecoxib Generic | 159 | 250 | 45 | $6,152 |
| Tramadol Hcl Generic | 139 | 142 | 61 | $588 |
| Humira(Cf) Pen Adalimumab | 135 | 137 | 21 | $986K |
| Methotrexate Methotrexate Sodium | 106 | 200 | 45 | $2,293 |
| Hydroxychloroquine Sulfate Generic | 95 | 226 | 32 | $3,251 |
| Rinvoq Upadacitinib | 70 | 70 | 15 | $461K |
| Diclofenac Sodium Generic | 44 | 56 | 22 | $2,184 |
| Xeljanz Xr Tofacitinib Citrate | 42 | 42 | Under 11 | $235K |
| Gabapentin Generic | 30 | 36 | Under 11 | $494 |
| Clonazepam Generic | 29 | 29 | Under 11 | $109 |
| Acthar Corticotropin | 27 | 36 | Under 11 | $2.3M |
| Enbrel Sureclick Etanercept | 26 | 37 | Under 11 | $237K |
| Prolia Denosumab | 24 | 141 | 18 | $41K |
| Kevzara Sarilumab | 22 | 26 | Under 11 | $110K |
Brand drugs: 435 claims; generic drugs: 1,162 claims; opioid claims: 199.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard M Bryan $82K ($82K in general payments such as food, travel and fees) from 16 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $79K.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 144 | $79K |
| Abbvie Inc. ABBV | 48 | $1,550 |
| Janssen Biotech, Inc. JNJ | 37 | $987 |
| UCB, Inc. UCB.BR | 10 | $331 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $275 |
| Pfizer Inc. PFE | 4 | $130 |
| GlaxoSmithKline, LLC. GSK | 5 | $128 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $116 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $78.59 |
| Aurinia Pharma U.S., Inc. AUPH | 2 | $52.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.